These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 29877295)

  • 1. Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.
    Harada-Shiba M; Arai H; Ishigaki Y; Ishibashi S; Okamura T; Ogura M; Dobashi K; Nohara A; Bujo H; Miyauchi K; Yamashita S; Yokote K;
    J Atheroscler Thromb; 2018 Aug; 25(8):751-770. PubMed ID: 29877295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolemia treatments: Guidelines and new therapies.
    Raal FJ; Hovingh GK; Catapano AL
    Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance for Pediatric Familial Hypercholesterolemia 2017.
    Harada-Shiba M; Ohta T; Ohtake A; Ogura M; Dobashi K; Nohara A; Yamashita S; Yokote K;
    J Atheroscler Thromb; 2018 Jun; 25(6):539-553. PubMed ID: 29415907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
    Turgeon RD; Barry AR; Pearson GJ
    Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022.
    Harada-Shiba M; Ohtake A; Sugiyama D; Tada H; Dobashi K; Matsuki K; Minamino T; Yamashita S; Yamamoto Y
    J Atheroscler Thromb; 2023 May; 30(5):531-557. PubMed ID: 36682777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
    Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
    Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
    Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.
    Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
    Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
    Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
    Farnier M; Civeira F; Descamps O;
    Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan.
    Harada-Shiba M; Arai H; Okamura T; Yokote K; Oikawa S; Nohara A; Okada T; Ohta T; Bujo H; Watanabe M; Wakatsuki A; Yamashita S
    J Atheroscler Thromb; 2012; 19(11):1019-26. PubMed ID: 23095241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.
    Ellis KL; Pang J; Schultz CJ; Watts GF
    Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011; 5(3):133-140. PubMed ID: 21600517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
    Masana L; Plana N; Pérez-Calahorra S; Ibarretxe D; Lamiquiz-Moneo I; Pedro-Botet J; Suárez-Tembra M; Valdivielso P; Ortega E; Civeira F;
    Atherosclerosis; 2017 Jul; 262():107-112. PubMed ID: 28531826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.